GlassScriptPhysician profile
Eric Thomas Walchak
NPI 1962493395
$2,790.99
in general payments reported to CMS, 2019-2025
12 companies · $462 in 2025
The $462 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,133 · 2020: $16.36 · 2021: $124 · 2022: $82.01 · 2023: $586 · 2024: $388 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,436.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $982.73 | 2019 | |
| Abiomed | $481.75 | 2023-2025 | Impella |
| Medtronic, INC. | $355.17 | 2022-2025 | Corevalve Evolut R, Venaseal, Symplicity G3 |
| Pfizer INC. | $215.22 | 2021-2025 | |
| Inari Medical, INC. | $204.03 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Edwards Lifesciences Corporation | $149.48 | 2023 | Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $144.20 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $104.26 | 2019-2025 | Watchman Access System |
| Terumo Medical Corporation | $60.28 | 2019-2025 | Angio-Seal, Tr Band |
| Medtronic Vascular, INC. | $42.61 | 2019 | |
| Zoll Circulation INC | $34.90 | 2024-2025 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Janssen Pharmaceuticals, INC | $16.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Walchak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.